Healthcare ❯Pharmaceuticals ❯Diabetes Medications ❯GLP-1 Receptor Agonists
A study suggests that the diabetes and weight-loss drug could lower opioid overdose risk in patients with Type 2 diabetes and opioid use disorder.
